ID   TAOK2_RAT               Reviewed;        1235 AA.
AC   Q9JLS3; A6BM05;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=Serine/threonine-protein kinase TAO2;
DE            EC=2.7.11.1;
DE   AltName: Full=Thousand and one amino acid protein 2;
GN   Name=Taok2; Synonyms=Tao2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   MAP2K3 AND MAP2K6.
RC   TISSUE=Brain;
RX   PubMed=10497253; DOI=10.1074/jbc.274.40.28803;
RA   Chen Z., Hutchison M., Cobb M.H.;
RT   "Isolation of the protein kinase TAO2 and identification of its mitogen-
RT   activated protein kinase/extracellular signal-regulated kinase kinase
RT   binding domain.";
RL   J. Biol. Chem. 274:28803-28807(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH PCDH8,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-57, AND PHOSPHORYLATION AT
RP   SER-1038 (ISOFORM 2).
RX   PubMed=17988630; DOI=10.1016/j.neuron.2007.08.020;
RA   Yasuda S., Tanaka H., Sugiura H., Okamura K., Sakaguchi T., Tran U.,
RA   Takemiya T., Mizoguchi A., Yagita Y., Sakurai T., De Robertis E.M.,
RA   Yamagata K.;
RT   "Activity-induced protocadherin arcadlin regulates dendritic spine number
RT   by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases.";
RL   Neuron 56:456-471(2007).
RN   [3] {ECO:0007744|PDB:1U5Q, ECO:0007744|PDB:1U5R}
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-320, AND PHOSPHORYLATION AT
RP   SER-181.
RX   PubMed=15458637; DOI=10.1016/j.str.2004.07.021;
RA   Zhou T., Raman M., Gao Y., Earnest S., Chen Z., Machius M., Cobb M.H.,
RA   Goldsmith E.J.;
RT   "Crystal structure of the TAO2 kinase domain: activation and specificity of
RT   a Ste20p MAP3K.";
RL   Structure 12:1891-1900(2004).
RN   [4] {ECO:0007744|PDB:2GCD}
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-320 IN COMPLEX WITH
RP   STAUROSPORINE, AND ACTIVITY REGULATION.
RX   PubMed=16761096; DOI=10.1111/j.1745-7270.2006.00173.x;
RA   Zhou T.J., Sun L.G., Gao Y., Goldsmith E.J.;
RT   "Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor
RT   staurosporine.";
RL   Acta Biochim. Biophys. Sin. 38:385-392(2006).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in different
CC       processes such as membrane blebbing and apoptotic bodies formation DNA
CC       damage response and MAPK14/p38 MAPK stress-activated MAPK cascade.
CC       Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and
CC       tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the
CC       specific activation and phosphorylation of the upstream MAP2K3 and
CC       MAP2K6 kinases. In response to DNA damage, involved in the G2/M
CC       transition DNA damage checkpoint by activating the p38/MAPK14 stress-
CC       activated MAPK cascade, probably by mediating phosphorylation of
CC       upstream MAP2K3 and MAP2K6 kinases. May affect microtubule organization
CC       and stability. May play a role in the osmotic stress-MAPK8 pathway.
CC       Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B
CC       activation. Isoform 2, but not isoform 1, is required for PCDH8
CC       endocytosis. Following homophilic interactions between PCDH8
CC       extracellular domains, isoform 2 phosphorylates and activates
CC       MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process
CC       leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms
CC       are involved in MAPK14/p38 MAPK activation.
CC       {ECO:0000269|PubMed:10497253, ECO:0000269|PubMed:17988630}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Moderately inhibited by staurosporine, a broad-
CC       range protein kinase inhibitor. {ECO:0000269|PubMed:16761096}.
CC   -!- SUBUNIT: Self-associates. Interacts with MAP2K3 and MAP2K6. Interacts
CC       with tubulins. Interacts with MAP3K7 and interferes with MAP3K7-binding
CC       to CHUK and thus prevents NF-kappa-B activation (By similarity).
CC       Isoform 2 interacts with PCDH8; this complex may also include CDH2.
CC       {ECO:0000250, ECO:0000269|PubMed:10497253, ECO:0000269|PubMed:16761096,
CC       ECO:0000269|PubMed:17988630}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=Found to be perinuclear and localized to vesicular
CC       compartment. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell projection, dendrite. Note=In
CC       dendrites, colocalizes with PCDH8.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=TAO2-alpha;
CC         IsoId=Q9JLS3-1; Sequence=Displayed;
CC       Name=2; Synonyms=TAO2-beta;
CC         IsoId=Q9JLS3-2; Sequence=VSP_040545, VSP_040546, VSP_040547;
CC   -!- PTM: Autophosphorylated. Phosphorylated by ATM (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: [Isoform 2]: Phosphorylated on Ser-1038 by MAPK14. This
CC       phosphorylation is required PCDH8 for endocytosis.
CC       {ECO:0000269|PubMed:15458637}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF140556; AAD39480.2; -; mRNA.
DR   EMBL; AB290408; BAF64457.1; -; mRNA.
DR   RefSeq; NP_073193.1; NM_022702.1. [Q9JLS3-1]
DR   PDB; 1U5Q; X-ray; 2.10 A; A/B=1-320.
DR   PDB; 1U5R; X-ray; 2.10 A; A/B=1-320.
DR   PDB; 2GCD; X-ray; 2.55 A; A/B=12-320.
DR   PDBsum; 1U5Q; -.
DR   PDBsum; 1U5R; -.
DR   PDBsum; 2GCD; -.
DR   AlphaFoldDB; Q9JLS3; -.
DR   SMR; Q9JLS3; -.
DR   IntAct; Q9JLS3; 1.
DR   STRING; 10116.ENSRNOP00000071896; -.
DR   BindingDB; Q9JLS3; -.
DR   ChEMBL; CHEMBL4523465; -.
DR   iPTMnet; Q9JLS3; -.
DR   PhosphoSitePlus; Q9JLS3; -.
DR   PaxDb; 10116-ENSRNOP00000061854; -.
DR   GeneID; 64666; -.
DR   KEGG; rno:64666; -.
DR   UCSC; RGD:621590; rat. [Q9JLS3-1]
DR   AGR; RGD:621590; -.
DR   CTD; 9344; -.
DR   RGD; 621590; Taok2.
DR   eggNOG; KOG0577; Eukaryota.
DR   InParanoid; Q9JLS3; -.
DR   OrthoDB; 2879376at2759; -.
DR   PhylomeDB; Q9JLS3; -.
DR   EvolutionaryTrace; Q9JLS3; -.
DR   PRO; PR:Q9JLS3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044295; C:axonal growth cone; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044294; C:dendritic growth cone; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:RGD.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; ISO:RGD.
DR   GO; GO:0038191; F:neuropilin binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0150020; P:basal dendrite arborization; IGI:ARUK-UCL.
DR   GO; GO:0150019; P:basal dendrite morphogenesis; IMP:ARUK-UCL.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; IDA:RGD.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0099179; P:regulation of synaptic membrane adhesion; IDA:SynGO.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; ISS:UniProtKB.
DR   CDD; cd06634; STKc_TAO2; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR051234; TAO_STE20_kinase.
DR   PANTHER; PTHR47167; SERINE/THREONINE-PROTEIN KINASE TAO1-LIKE PROTEIN; 1.
DR   PANTHER; PTHR47167:SF6; SERINE_THREONINE-PROTEIN KINASE TAO2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell projection;
KW   Coiled coil; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Kinase;
KW   Magnesium; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..1235
FT                   /note="Serine/threonine-protein kinase TAO2"
FT                   /id="PRO_0000086735"
FT   TRANSMEM        967..987
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        989..1009
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1014..1034
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1040..1060
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1170..1190
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..281
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          318..457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          892..941
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1210..1235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          488..523
FT                   /evidence="ECO:0000255"
FT   COILED          576..603
FT                   /evidence="ECO:0000255"
FT   COILED          683..715
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        344..373
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        374..397
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        922..939
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        151
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         34..42
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         106..108
FT                   /ligand="staurosporine"
FT                   /ligand_id="ChEBI:CHEBI:57491"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000269|PubMed:16761096,
FT                   ECO:0007744|PDB:2GCD"
FT   BINDING         155
FT                   /ligand="staurosporine"
FT                   /ligand_id="ChEBI:CHEBI:57491"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000269|PubMed:16761096,
FT                   ECO:0007744|PDB:2GCD"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL54"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15458637"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL54"
FT   MOD_RES         658
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZQ29"
FT   MOD_RES         777
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL54"
FT   MOD_RES         825
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL54"
FT   MOD_RES         827
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL54"
FT   VAR_SEQ         333
FT                   /note="E -> ELTPCSQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17988630"
FT                   /id="VSP_040545"
FT   VAR_SEQ         747..1050
FT                   /note="VRAGQLPMGLPATGALGPLSTGTLSEEQPCSSGQEAILGQRMLGEEEEAVPE
FT                   RMILGKEGTTLEPEEQRILGEEMGTFSSSPQKHRSLVNEEDWDISKEMKESRVPSLASQ
FT                   ERNIIGQEEAGAWNLWEKEHGNLVDMEFKLGWVQGPVLTPVPEEEEEEEEEGGAPIGTP
FT                   RDPGDGCPSPDIPPEPPPSHLRQYPASQLPGFLSHGLLTGLSFAVGSSSGLLPLLLLLL
FT                   LPLLAAQGGGGLQAALLALEVGLVGLGASYLFLCTALHLPPSLFLLLAQGTALGAVLSL
FT                   SWRRGLMGVPLGLGAA -> SKELQIKKQFQETCKIQTRQYKALRAHLLETTPKAQHKS
FT                   LVKRLKEEQTRKLAILAEQYDQSISEMLSSQALRLDETQEAEFQALRQRSNRNWSSLML
FT                   TRARSKIRTESQHERELRELEQRVALRRALLEQRVEEELLALQTGRSERIRSLLERQAR
FT                   EIEAFDAESMRLGFSSMALGGIPAEAAAQGYPAPPPAPAWPSRPVPRSGAHWSHGPPPP
FT                   GMPPPAWRXPALLAPPGPPNWLGPPTQSGTPSGGALLLLRNSPQPLKRAASGGSSGENV
FT                   GPPAAVPGPLSRSTSVASHILNGSSHFYS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17988630"
FT                   /id="VSP_040546"
FT   VAR_SEQ         1051..1235
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17988630"
FT                   /id="VSP_040547"
FT   MUTAGEN         57
FT                   /note="K->A: Loss of activity. Loss of MAPK14
FT                   phosphorylation and of PCDH8 internalization."
FT                   /evidence="ECO:0000269|PubMed:17988630"
FT   CONFLICT        434
FT                   /note="P -> L (in Ref. 2; BAF64457)"
FT                   /evidence="ECO:0000305"
FT   HELIX           13..18
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           24..27
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          28..36
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          38..47
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   TURN            48..51
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          52..61
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           66..82
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          100..106
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           112..119
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           125..144
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           154..156
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   TURN            161..163
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          174..179
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           186..188
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           191..195
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   TURN            196..199
FT                   /evidence="ECO:0007829|PDB:2GCD"
FT   HELIX           205..220
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   TURN            224..227
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           230..239
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           252..261
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           266..268
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           272..275
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           279..282
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           289..303
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:2GCD"
FT   HELIX           307..309
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   HELIX           311..319
FT                   /evidence="ECO:0007829|PDB:1U5Q"
FT   MOD_RES         Q9JLS3-2:1038
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17988630"
SQ   SEQUENCE   1235 AA;  138751 MW;  426960D0812518AD CRC64;
     MPAGGRAGSL KDPDVAELFF KDDPEKLFSD LREIGHGSFG AVYFARDVRN SEVVAIKKMS
     YSGKQSNEKW QDIIKEVRFL QKLRHPNTIQ YRGCYLREHT AWLVMEYCLG SASDLLEVHK
     KPLQEVEIAA VTHGALQGLA YLHSHNMIHR DVKAGNILLS EPGLVKLGDF GSASIMAPAN
     SFVGTPYWMA PEVILAMDEG QYDGKVDVWS LGITCIELAE RKPPLFNMNA MSALYHIAQN
     ESPALQSGHW SEYFRNFVDS CLQKIPQDRP TSEVLLKHRF VLRERPPTVI MDLIQRTKDA
     VRELDNLQYR KMKKILFQEA PNGPGAEAPE EEEEAEPYMH RAGTLTSLES SHSVPSMSIS
     ASSQSSSVNS LADASDNEEE EEEEEEEEEE EEEEGPESRE MAMMQEGEHT VTSHSSIIHR
     LPGSDNLYDD PYQPEMTPGP LQPPAAPPTS TSSSSARRRA YCRNRDHFAT IRTASLVSRQ
     IQEHEQDSAL REQLSGYKRM RRQHQKQLLA LESRLRGERE EHSGRLQREL EAQRAGFGTE
     AEKLARRHQA IGEKEARAAQ AEERKFQQHI LGQQKKELAA LLEAQKRTYK LRKEQLKEEL
     QENPSTPKRE KAEWLLRQKE QLQQCQAEEE AGLLRRQRQY FELQCRQYKR KMLLARHSLD
     QDLLREDLNK KQTQKDLECA LLLRQHEATR ELELRQLQAV QRTRAELTRL QHQTELGNQL
     EYNKRREQEL RQKHAAQVRQ QPKSLKVRAG QLPMGLPATG ALGPLSTGTL SEEQPCSSGQ
     EAILGQRMLG EEEEAVPERM ILGKEGTTLE PEEQRILGEE MGTFSSSPQK HRSLVNEEDW
     DISKEMKESR VPSLASQERN IIGQEEAGAW NLWEKEHGNL VDMEFKLGWV QGPVLTPVPE
     EEEEEEEEGG APIGTPRDPG DGCPSPDIPP EPPPSHLRQY PASQLPGFLS HGLLTGLSFA
     VGSSSGLLPL LLLLLLPLLA AQGGGGLQAA LLALEVGLVG LGASYLFLCT ALHLPPSLFL
     LLAQGTALGA VLSLSWRRGL MGVPLGLGAA WLLAWPSLAL PLAAMAAGGK WVRQQGPQMR
     RGISRLWLRV LLRLSPMVFR ALQGCAAVGD RGLFALYPKT NKNGFRSRLP VPWPRQGNPR
     TTQHPLALLA RVWALCKGWN WRLARASHRL ASCLPPWAVH ILASWGLLKG ERPSRIPRLL
     PRSQRRLGLS ASRQLPPGTV AGRRSQTRRA LPPWR
//
